Insider Trading Summary for Apellis Pharmaceuticals, Inc. (APLS): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
02-Jan-24 4:10 PM View:	01-Jan-24 Grant 0	Chan Gerald Director		Apellis Pharmaceuticals, Inc. - APLS	41% 8.1K to 11.44K	0	0	--	--	Show Txns Hide Txns

24-Sep-24 4:20 PM View:	23-Sep-24 Option Exercise $60.67K	Dunlop A. Sinclair Director		Apellis Pharmaceuticals, Inc. - APLS	(32%) 370.94K to 252.13K	0	($1.45M) (10%)	--	$39.24	Show Txns Hide Txns

02-Jan-24 4:08 PM View:	01-Jan-24 Grant 0	MacHiels Alec Director		Apellis Pharmaceuticals, Inc. - APLS	0% 779.37K to 782.71K	0	0	--	--	Show Txns Hide Txns

02-Jan-24 4:12 PM View:	01-Jan-24 Grant 0	O'Brien Stephanie Monaghan Director		Apellis Pharmaceuticals, Inc. - APLS	41% 8.1K to 11.44K	0	0	--	--	Show Txns Hide Txns

30-Sep-24 4:15 PM View:	27-Sep-24 Gift 0	Watson David O. General Counsel		Apellis Pharmaceuticals, Inc. - APLS	12% 176.46K to 197.86K	0	0	--	--	Show Txns Hide Txns

19-Apr-24 7:27 PM View:	18-Apr-24 Gift 0	Sullivan Timothy Eugene Chief Financial Officer		Apellis Pharmaceuticals, Inc. - APLS	12% 133.94K to 149.57K	0	0	--	--	Show Txns Hide Txns

02-Jan-24 4:13 PM View:	01-Jan-24 Grant 0	Fonteyne Paul R. Director		Apellis Pharmaceuticals, Inc. - APLS	26% 13.1K to 16.44K	0	0	--	--	Show Txns Hide Txns

31-Jan-24 4:28 PM View:	30-Jan-24 Sale (Planned) ($57.86K)	Lewis Karen Chief People Officer		Apellis Pharmaceuticals, Inc. - APLS	11% 41.61K to 46.39K	0	0	--	--	Show Txns Hide Txns

14-Mar-24 4:17 PM View:	13-Mar-24 Private Sale ($645.84K)	Nicholson Nur Chief Technical Officer		Apellis Pharmaceuticals, Inc. - APLS	6% 53.28K to 56.29K	0	0	--	--	Show Txns Hide Txns

21-May-24 4:03 PM View:	20-May-24 Option Exercise $92.12K	Deschatelets Pascal Chief Scientific Officer		Apellis Pharmaceuticals, Inc. - APLS	2% 1.12M to 1.14M	0	0	--	--	Show Txns Hide Txns

13-Feb-24 5:05 PM View:	12-Feb-24 Private Sale ($77.80K)	Townsend Adam J. Chief Commercial Officer		Apellis Pharmaceuticals, Inc. - APLS	21% 76.41K to 92.45K	0	0	--	--	Show Txns Hide Txns

17-Sep-24 4:08 PM View:	16-Sep-24 Sale ($6.95K)	Chopas James George VP/Chief Accounting Officer		Apellis Pharmaceuticals, Inc. - APLS	17% 32.68K to 38.14K	0	0	--	--	Show Txns Hide Txns

17-Jan-24 4:33 PM View:	16-Jan-24 Grant 0	Baumal Caroline Chief Medical Officer		Apellis Pharmaceuticals, Inc. - APLS	64% 35.68K to 58.38K	0	0	--	--	Show Txns Hide Txns

13-Aug-24 4:13 PM View:	12-Aug-24 Option Exercise $72.03K	Delong Mark Jeffrey Chief Business & Strat Officer		Apellis Pharmaceuticals, Inc. - APLS	17% 51.62K to 60.4K	0	0	--	--	Show Txns Hide Txns

31-Jan-24 4:23 PM View:	30-Jan-24 Sale (Planned) ($63.63K)	Eisele Jeffrey Chief Development Officer		Apellis Pharmaceuticals, Inc. - APLS	6% 53.88K to 57.21K	0	0	--	--	Show Txns Hide Txns

05-Dec-23 7:40 PM View:	01-Dec-23 Planned Option Sale ($600.00K)	Scheibler Lukas Chief Research Officer		Apellis Pharmaceuticals, Inc. - APLS	0% 68.3K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:07 PM View:	01-Mar-24 Option Sale ($16.03M)	Francois Cedric Chief Executive Officer Director		Apellis Pharmaceuticals, Inc. - APLS	2% 1.99M to 2.04M	0	0	--	--	Show Txns Hide Txns

Apellis Pharmaceuticals, Inc. (APLS)

Last Year

23-Nov-23 -- 22-Nov-24

Company Sentiment

Other

Other

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Buy:	0	--
Sell:	($1.45M)	$39.24